Literature DB >> 10878872

Bronchial asthma: recent advances.

R K Kumar1.   

Abstract

Asthma is one of the oldest diseases about which there are lots of myths in most parts of the world. The exact cause of this global disease still eludes scientists. The recent knowledge about the pathogenesis of the disease, led to rationalise the medications into different groups. Parallel to the increasing incidence of this disease, is the knowledge about the trigger factors and steps to reduce their exposure. Childhood asthma is a lot different from asthma in adults, as many children won't be able to use the inhalers like adults and most children will not be able to do lung function tests until they are about 6 years of age. Unlike for any other diseases, research has helped year after year in developing new strategies for management of asthma. Starting from definition of the disease to inventing newer medications, management of asthma has revolutionised in the last few years and has also accounted for the decreasing mortality in many countries. This article tries to give an overview of bronchial asthma in children including recent advances and possible future developments.

Entities:  

Mesh:

Year:  2000        PMID: 10878872     DOI: 10.1007/bf02758176

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN: 0019-5456            Impact factor:   1.967


  15 in total

Review 1.  Asthma: a follow up statement from an international paediatric asthma consensus group.

Authors: 
Journal:  Arch Dis Child       Date:  1992-02       Impact factor: 3.791

2.  Lung function improvement in asthma with a cysteinyl-leukotriene receptor antagonist.

Authors:  K P Hui; N C Barnes
Journal:  Lancet       Date:  1991-05-04       Impact factor: 79.321

Review 3.  The future of asthma.

Authors:  I P Hall
Journal:  BMJ       Date:  1997-01-04

4.  Asthma--time for a change of name?

Authors:  M Silverman; N Wilson
Journal:  Arch Dis Child       Date:  1997-07       Impact factor: 3.791

Review 5.  Immunosuppressive treatment in asthma.

Authors:  O M Kon; N Barnes
Journal:  Br J Hosp Med       Date:  1997 Apr 16-May 6

Review 6.  Managing asthma: a growth and development approach.

Authors:  P Ladebauche
Journal:  Pediatr Nurs       Date:  1997 Jan-Feb

7.  Worldwide variation in prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and atopic eczema: ISAAC. The International Study of Asthma and Allergies in Childhood (ISAAC) Steering Committee.

Authors: 
Journal:  Lancet       Date:  1998-04-25       Impact factor: 79.321

Review 8.  Leukotrienes as a target in asthma therapy.

Authors:  N Chanarin; S L Johnston
Journal:  Drugs       Date:  1994-01       Impact factor: 9.546

9.  Leukotrienes: mediators of immediate hypersensitivity reactions and inflammation.

Authors:  B Samuelsson
Journal:  Science       Date:  1983-05-06       Impact factor: 47.728

10.  Persistent increase in plasma and urinary leukotrienes after acute asthma.

Authors:  A P Sampson; D P Castling; C P Green; J F Price
Journal:  Arch Dis Child       Date:  1995-09       Impact factor: 3.791

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.